Effect of the Fetal THRB Genotype on the Placenta
The Journal of Clinical Endocrinology & Metabolism · 18.09.2023 · 108 (10) · e944-e948
DOI: 10.1210/clinem/dgad243 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 07.05.2023. Verfasst von Federico Salas-Lucia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Medicine, University of Chicago, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: Placenta, Genes, erbA. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Context
Pregnant women with mutations in the thyroid hormone receptor beta (THRB) gene expose their fetuses to high thyroid hormone (TH) levels shown to be detrimental to a normal fetus (NlFe) but not to an affected fetus (AfFe). However, no information is available about differences in placental TH regulators.
Objective
To investigate whether there are differences in placentas associated with a NlFe compared with an AfFe, we had the unique opportunity to study placentas from 2 pregnancies of the same woman with THRB mutation G307D. One placenta supported a NlFe while the other an AfFe.
Methods
Sections of placentas were collected and frozen at −80 °C after term delivery of a NlFe and an AfFe. Two placentas from healthy women of similar gestational age were also obtained. The fetal origin of the placental tissues was established by gDNA quantitation of genes on the X and Y chromosomes and THRB gene. Expression and enzymatic activity of deiodinases 2 and 3 were measured. Expression of following genes was also quantitated: MCT10, MCT8, LAT1, LAT2, THRB, THRA.
Results
The placenta carrying the AfFe exhibited a significant reduction of deiodinase 2 and 3 activities as well as the expression of the TH transporters MCT10, LAT1 and LAT2, and THRA.
Conclusion
We present the first study of the effect of the fetal THRB genotype on the placenta. Though limited by virtue of the rarity of THRB mutations and sample availability, we show that the fetal THRB genotype influences the levels of TH regulators in the placenta.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Medicine, University of Chicago, Chicago, IL 60637, USA.
- Division of Endocrinology, Mayo Clinic, Rochester, MN 55905, USA.
- Departments of Molecular Metabolism and Nutrition, University of Chicago, Chicago, IL 60637, USA.
- Departments of Pediatrics, University of Chicago, Chicago, IL 60637.
- Departments of Committees on Genetics, University of Chicago, Chicago, IL 60637, USA.
ORCID-Profile: Federico Salas-Lucia, Samuel Refetoff
Förderung
- NIDDK NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Salas-Lucia, F., Stan, M. N., James, H., Rajwani, A., Liao, X. H., Dumitrescu, A. M., & Refetoff, S. (2023). Effect of the Fetal THRB Genotype on the Placenta. The Journal of Clinical Endocrinology & Metabolism, 108(10), e944-e948. https://doi.org/10.1210/clinem/dgad243
Vancouver
Salas-Lucia F, Stan MN, James H, Rajwani A, Liao XH, Dumitrescu AM, et al. Effect of the Fetal THRB Genotype on the Placenta. The Journal of Clinical Endocrinology & Metabolism. 2023;108(10):e944-e948. doi:10.1210/clinem/dgad243
BibTeX
@article{SalasLucia2023,
author = {Salas-Lucia, Federico and Stan, Marius N and James, Haleigh and Rajwani, Aadil and Liao, Xiao-Hui and Dumitrescu, Alexandra M and Refetoff, Samuel},
title = {Effect of the Fetal THRB Genotype on the Placenta},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
volume = {108},
number = {10},
pages = {e944--e948},
doi = {10.1210/clinem/dgad243}
}
EUVIMED